Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Nanomolar concentration of alpha-synuclein enhances dopaminergic neuronal survival via Akt pathway.

Kim JY, Jeon BS, Kim HJ, Ahn TB.

Neural Regen Res. 2013 Dec 15;8(35):3269-74. doi: 10.3969/j.issn.1673-5374.2013.35.001.

PMID:
25206648
[PubMed]
Free PMC Article
2.

Epitope Mapping of Antibodies to Alpha-Synuclein in LRRK2 Mutation Carriers, Idiopathic Parkinson Disease Patients, and Healthy Controls.

Alvarez-Castelao B, Gorostidi A, Ruíz-Martínez J, López de Munain A, Castaño JG.

Front Aging Neurosci. 2014 Jul 15;6:169. doi: 10.3389/fnagi.2014.00169. eCollection 2014.

PMID:
25076905
[PubMed]
Free PMC Article
3.

Rationale for therapeutic silencing of alpha-synuclein in Parkinson's disease.

Maraganore DM.

J Mov Disord. 2011 May;4(1):1-7. doi: 10.14802/jmd.11001. Epub 2011 Apr 30. Review.

PMID:
24868385
[PubMed]
Free PMC Article
4.

Protein phosphorylation in neurodegeneration: friend or foe?

Tenreiro S, Eckermann K, Outeiro TF.

Front Mol Neurosci. 2014 May 13;7:42. doi: 10.3389/fnmol.2014.00042. eCollection 2014. Review.

PMID:
24860424
[PubMed]
Free PMC Article
5.

Towards translational therapies for multiple system atrophy.

Kuzdas-Wood D, Stefanova N, Jellinger KA, Seppi K, Schlossmacher MG, Poewe W, Wenning GK.

Prog Neurobiol. 2014 Jul;118:19-35. doi: 10.1016/j.pneurobio.2014.02.007. Epub 2014 Mar 2.

PMID:
24598411
[PubMed - in process]
Free PMC Article
6.

The role of innate and adaptive immunity in Parkinson's disease.

Kannarkat GT, Boss JM, Tansey MG.

J Parkinsons Dis. 2013;3(4):493-514. doi: 10.3233/JPD-130250. Review.

PMID:
24275605
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Evidence for prion-like mechanisms in several neurodegenerative diseases: potential implications for immunotherapy.

Marciniuk K, Taschuk R, Napper S.

Clin Dev Immunol. 2013;2013:473706. doi: 10.1155/2013/473706. Epub 2013 Oct 20. Review.

PMID:
24228054
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathy.

Theunis C, Crespo-Biel N, Gafner V, Pihlgren M, López-Deber MP, Reis P, Hickman DT, Adolfsson O, Chuard N, Ndao DM, Borghgraef P, Devijver H, Van Leuven F, Pfeifer A, Muhs A.

PLoS One. 2013 Aug 19;8(8):e72301. doi: 10.1371/journal.pone.0072301. eCollection 2013.

PMID:
23977276
[PubMed - in process]
Free PMC Article
9.

Immunity and inflammation in neurodegenerative diseases.

Cappellano G, Carecchio M, Fleetwood T, Magistrelli L, Cantello R, Dianzani U, Comi C.

Am J Neurodegener Dis. 2013 Jun 21;2(2):89-107. Print 2013.

PMID:
23844334
[PubMed]
Free PMC Article
10.

Prion-like propagation of protein aggregation and related therapeutic strategies.

Kaufman SK, Diamond MI.

Neurotherapeutics. 2013 Jul;10(3):371-82. doi: 10.1007/s13311-013-0196-3. Review.

PMID:
23801258
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Altered serum IgG levels to α-synuclein in dementia with Lewy bodies and Alzheimer's disease.

Koehler NK, Stransky E, Shing M, Gaertner S, Meyer M, Schreitmüller B, Leyhe T, Laske C, Maetzler W, Kahle P, Celej MS, Jovin TM, Fallgatter AJ, Batra A, Buchkremer G, Schott K, Richartz-Salzburger E.

PLoS One. 2013 May 31;8(5):e64649. doi: 10.1371/journal.pone.0064649. Print 2013.

PMID:
23741358
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Developing therapeutic antibodies for neurodegenerative disease.

Yu YJ, Watts RJ.

Neurotherapeutics. 2013 Jul;10(3):459-72. doi: 10.1007/s13311-013-0187-4. Review.

PMID:
23549647
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity.

Sanchez-Guajardo V, Barnum CJ, Tansey MG, Romero-Ramos M.

ASN Neuro. 2013 Apr 30;5(2):113-39. doi: 10.1042/AN20120066. Review.

PMID:
23506036
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats.

Nuber S, Harmuth F, Kohl Z, Adame A, Trejo M, Schönig K, Zimmermann F, Bauer C, Casadei N, Giel C, Calaminus C, Pichler BJ, Jensen PH, Müller CP, Amato D, Kornhuber J, Teismann P, Yamakado H, Takahashi R, Winkler J, Masliah E, Riess O.

Brain. 2013 Feb;136(Pt 2):412-32. doi: 10.1093/brain/aws358.

PMID:
23413261
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.

Valera E, Masliah E.

Pharmacol Ther. 2013 Jun;138(3):311-22. doi: 10.1016/j.pharmthera.2013.01.013. Epub 2013 Feb 4. Review.

PMID:
23384597
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Cerebrospinal fluid biomarker candidates for parkinsonian disorders.

Constantinescu R, Mondello S.

Front Neurol. 2013 Jan 21;3:187. doi: 10.3389/fneur.2012.00187. eCollection 2012.

PMID:
23346074
[PubMed]
Free PMC Article
17.

Axonopathy in an α-synuclein transgenic model of Lewy body disease is associated with extensive accumulation of C-terminal-truncated α-synuclein.

Games D, Seubert P, Rockenstein E, Patrick C, Trejo M, Ubhi K, Ettle B, Ghassemiam M, Barbour R, Schenk D, Nuber S, Masliah E.

Am J Pathol. 2013 Mar;182(3):940-53. doi: 10.1016/j.ajpath.2012.11.018. Epub 2013 Jan 9.

PMID:
23313024
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Movement disorders in 2012: Advancing research towards novel therapeutic approaches.

McFarland NR, Okun MS.

Nat Rev Neurol. 2013 Feb;9(2):70-1. doi: 10.1038/nrneurol.2012.265. Epub 2013 Jan 8. Review.

PMID:
23296342
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

α-Synuclein and anti-α-synuclein antibodies in Parkinson's disease, atypical Parkinson syndromes, REM sleep behavior disorder, and healthy controls.

Smith LM, Schiess MC, Coffey MP, Klaver AC, Loeffler DA.

PLoS One. 2012;7(12):e52285. doi: 10.1371/journal.pone.0052285. Epub 2012 Dec 17.

PMID:
23284971
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Amyotrophic lateral sclerosis and organ donation: is there risk of disease transmission?

Holmes BB, Diamond MI.

Ann Neurol. 2012 Dec;72(6):832-6. doi: 10.1002/ana.23684. Review.

PMID:
23280834
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk